Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Cell Count × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Thoracic 1 CNS 1

Conditions

Interventions

Temozolomide 61 Magnetic Resonance Spectroscopy 56 Specimen Handling 36 Radiotherapy 35 Radiosurgery 30 Cyclophosphamide 22 Bevacizumab 22 pembrolizumab 19 Radiation 14 Blood Specimen Collection 14 fludarabine 12 Irinotecan 12 Pemetrexed 11 Lomustine 11 Nivolumab 10 Etoposide 10 Carboplatin 10 Biopsy 10 Vincristine 9 trametinib 8 lutetium Lu 177 dotatate 8 Surgical Procedures, Operative 8 Fluorodeoxyglucose F18 8 naxitamab 7 fluciclovine F-18 7 Everolimus 7 Drug Therapy 7 olaparib 6 gallium Ga 68 dotatate 6 dinutuximab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07144735 2025-08-27

ABOUT

Peking University Third Hospital

Phase NA Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡